ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
高瓴概念
509.221
-4.923
-0.96%
手动刷新
涨家数:
14
跌家数:
38
平家数:
3
市盈率:
- -
高:
515.982
开:
514.177
低:
504.033
收:
514.144
成交量:
4.07亿
成交额:
96.44亿
市值:
3.02万亿
流通市值:
2.28万亿
数据加载中...
总览
新闻资讯
集采落地后的国产正畸“黑马”:美立刻突然停服,万名患者权益保障成焦点
华夏时报网
·
1小时前
春雨医生“卖身”:一场 “骨折价” 收购
财中社
·
1小时前
每日卖空追踪 | 德琪医药-B 12月16日卖空量成交10.6万股,卖空比例为4.8%
市场透视
·
1小时前
东方财富证券:创新浪潮涌动下 关注医药板块修复与突破
智通财经
·
1小时前
中升控股12月16日遭主力抛售43.4万元
市场透视
·
2小时前
德琪医药-B12月16日遭主力抛售53.5万元
市场透视
·
2小时前
中国铁塔12月16日遭主力抛售2375.7万元
市场透视
·
2小时前
绩效新规|东方红资产管理10年给东方证券分红31.7亿,2022至2023给基民亏480亿元分红率却连续两年超过86%
新浪基金
·
2小时前
GLP-1赛道或再扩容!信达生物玛仕度肽青少年Ib期临床研究达主要终点 抢滩百亿减重市场
蓝鲸新闻
·
3小时前
【医疗与消费周度观点】创新药行业研发突破与市场演进的并行
大胡子产业经济
·
4小时前
百融云创旗下数融小贷新上任一副总经理
蓝鲸财经
·
4小时前
房企司法重整第一股诞生!涉及债务规模达1470亿元,债权人数量超8400家,金科股份历时两年半完成重整
每日经济新闻
·
6小时前
最新消息! 药明巨诺前CEO刘敏加盟博锐生物
药研网
·
6小时前
医疗健康产业日报(12.15) : "医药行业动态:融资、研发与政策利好"
亿欧
·
7小时前
西安市科技局2024年预算编制不精准、项目管理不到位、资产管理不规范
澎湃新闻
·
7小时前
港股异动 | 光伏股再度走弱 光伏协会确认收储平台成立 光伏玻璃价格仍然承压
智通财经
·
7小时前
美团找房低调上线仍处测试阶段,合作接入房源未设独立入口
中华建设网
·
7小时前
《股市简讯》中国民营肿瘤医院集团海吉亚医疗涨6.5%,拟斥至少3亿元回购股份
路透中文
·
8小时前
海吉亚医疗(06078.HK)早盘涨近6%
每日经济新闻
·
8小时前
【券商聚焦】海通国际:医药板块短期承压 长期看好创新药产业链
金吾财讯
·
8小时前
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1583/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":509.22144,"timestamp":1765872498184,"preClose":514.1442,"halted":0,"volume":406672930,"delay":0,"changeRate":-0.009575,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-4.922791,"latestTime":"12-16 16:00:00","open":514.17664,"high":515.98157,"low":504.03333,"amount":9644256886,"amplitude":0.023239,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1765848600000,1765857600000],[1765861200000,1765872000000]],"pbRate":2.413651,"peRate":28.969076,"turnoverRate":0.002762,"increases":13,"decrements":36,"flats":4,"marketCap":3018194888256,"floatMarketCap":2277912338496},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":515.98157,"amplitude":0.023239,"preClose":514.1442,"low":504.03333,"pbRate":"2.413651","latestPrice":509.22144,"volume":406672930,"delay":0,"open":514.17664,"prevYearClose":446.93042,"prevWeekClose":530.832,"prevMonthClose":541.036,"prevQuarterClose":552.537,"fiveDayClose":520.133,"twentyDayClose":541.283,"sixtyDayClose":555.797,"secType":"PLATE","market":"HK","turnoverRate":0.002762,"peRate":28.969076,"marketCap":3018194888256,"floatMarketCap":2277912338496,"timestamp":1765872498184,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":14,"down":38,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2591607496","title":"集采落地后的国产正畸“黑马”:美立刻突然停服,万名患者权益保障成焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=2591607496","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591607496?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 17:04","pubTimestamp":1765875862,"startTime":"0","endTime":"0","summary":"集采政策实施不到一年,国产隐形正畸“黑马”宣告退场,上万名患者治疗面临中断风险。2025年12月初,国产隐形正畸品牌美立刻宣布因“技术和运营问题”无法继续提供服务。作为2025年正畸集采落地后,首个因运营承压退出市场的国产主流品牌,美立刻的停服事件迅速在行业内引发连锁反应,包括全国1800余个城市的万名在治患者及近5万家合作门诊。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512163593077930.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512163593077930.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1100","06699","BK1587","BK1593"],"gpt_icon":0},{"id":"2591602456","title":"春雨医生“卖身”:一场 “骨折价” 收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2591602456","media":"财中社","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591602456?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 16:31","pubTimestamp":1765873907,"startTime":"0","endTime":"0","summary":"12月5日,港股上市公司国锐生活(00108.HK)发布公告称,拟以2.69亿元对价收购互联网医疗平台春雨医生78.3%股权。由此计算,春雨医生对应整体估值仅约3.44亿元。交易采用“20%现金+80%股份”方式,较市价折让近60%,且需通过VIE(可变利益实体)架构规避外资持股限制。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512163593044317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["89618","LU0828237510.HKD","LU0417516738.SGD","BK1142","LU0327786744.USD","LU0791591158.USD","86618","LU0359201612.USD","LU0456846285.SGD","06618","LU1366334651.USD","LU1251922891.USD","LU0588545730.USD","LU1642822792.SGD","00241","LU0259732245.USD","LU0588546209.SGD","LU1794554557.SGD","BK1571","LU1224444064.USD","BK1189","LU0456827905.SGD","IE0032431581.USD","01833","LU1282651121.HKD","LU2039709279.SGD","BK1515","LU1044875133.USD","IE00B3M56506.USD","LU0228367735.SGD","LU0871576103.HKD","LU1366334578.USD","LU0469268626.HKD","LU0488056044.USD","LU2257852520.SGD","IE00B29SXG58.USD","LU1044876610.USD","LU0865486749.SGD","00108","LU2242644610.SGD","LU0417516902.SGD","LU1023057109.AUD","BK1583","BK1249","LU0384037296.USD","LU0128522157.USD","BK1247","LU0348805143.USD","LU1770034418.SGD"],"gpt_icon":1},{"id":"2591260776","title":"每日卖空追踪 | 德琪医药-B 12月16日卖空量成交10.6万股,卖空比例为4.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591260776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591260776?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 16:30","pubTimestamp":1765873835,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间12月16日,跌3.38%,卖空量成交10.6万股,较上一交易日减少41.11%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163614a451a0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163614a451a0fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","BK1583","06996"],"gpt_icon":0},{"id":"2591022646","title":"东方财富证券:创新浪潮涌动下 关注医药板块修复与突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2591022646","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591022646?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 16:25","pubTimestamp":1765873557,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,东方财富证券发布研报称,随着中国创新药License-out项目总金额创下新纪录,临床前项目占比持续保持高位,ADC、双/多抗、小核酸等新兴疗法,以及代谢领域中肥胖适应症等或为未来License-out项目的重点方向。东方财富证券主要观点如下:今年以来,在创新药、AI医疗的带动下,化学制药板块领涨医药板块估值水平接近最近10年历史平均水平。中国创新药十年变革主要得益于全面的监管改革、研发投入的增加以及战略性的全球化布局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","SG9999014674.SGD","LU0307460666.USD","IE00BZ08YS42.EUR","LU2543165471.USD","LU1997244956.HKD","LU0588546209.SGD","09939","BK0188","LU2097828805.USD","BK0095","159938","BK0077","BK0028","LU2148510915.USD","BK1521","BK1191","LU1719994722.HKD","LU2328871848.SGD","LU0326950275.SGD","IE00BZ08YR35.GBP","LU1064131003.USD","LU1997245177.USD","01177","LU0359202008.SGD","LU1969619763.USD","LU2097828631.EUR","HK0000165453.HKD","LU2495084118.USD","LU2097828714.EUR","300059","BK1583","IE00BZ08YT58.USD","LU2580892789.USD","06160","01276","LU1303224171.USD","LU1831875114.USD","161027","BK1500","LU2289578879.USD","BK1515","BK0196","LU2097828474.EUR","LU2097828557.USD","LU1770034418.SGD","BK1588","BK1589","LU1251922891.USD"],"gpt_icon":0},{"id":"2591876607","title":"中升控股12月16日遭主力抛售43.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591876607","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591876607?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 16:16","pubTimestamp":1765872965,"startTime":"0","endTime":"0","summary":"12月16日, 中升控股股价跌2.03%,报收11.09元,成交金额3884.5万元,换手率0.15%,振幅2.74%,量比0.70。中升控股今日主力资金净流出43.4万元,连续3日净流出,上一交易日主力净流出377.8万元。该股近5个交易日下跌1.50%,主力资金累计净流出1152.5万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入2015.4万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162346a45192a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162346a45192a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00881","LU0173614495.USD","SG9999001226.SGD","BK1239","BK1589","BK1520","BK1583","LU1102505762.USD","LU0287142896.SGD"],"gpt_icon":0},{"id":"2591607200","title":"德琪医药-B12月16日遭主力抛售53.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591607200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591607200?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 16:15","pubTimestamp":1765872945,"startTime":"0","endTime":"0","summary":"12月16日, 德琪医药-B股价跌3.38%,报收4.00元,成交金额877.9万元,换手率0.32%,振幅6.04%,量比1.25。德琪医药-B今日主力资金净流出53.5万元,上一交易日主力净流出65.6万元。该股近5个交易日下跌8.66%,主力资金累计净流出51.5万元;近20日主力资金累计净流出381.8万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162001a6a8a52c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162001a6a8a52c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06996","BK1191","BK1574"],"gpt_icon":0},{"id":"2591604149","title":"中国铁塔12月16日遭主力抛售2375.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591604149","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591604149?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 16:15","pubTimestamp":1765872911,"startTime":"0","endTime":"0","summary":"12月16日, 中国铁塔股价跌2.21%,报收11.93元,成交金额2.4亿元,换手率0.44%,振幅2.13%,量比1.46。中国铁塔今日主力资金净流出2375.7万元,上一交易日主力净流出395.8万元。该股近5个交易日下跌3.73%,主力资金累计净流出1014.0万元;近20日主力资金累计净流入3.2亿元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216161550a4518908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216161550a4518908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1133","BK1506","IE00BHRH8C09.USD","BK1521","BK1529","BK1589","00788","IE00BG0RBZ43.SGD","LU0823413587.USD","BK1583","LU0823413660.USD","IE00BHRH8D16.HKD"],"gpt_icon":0},{"id":"2591601457","title":"绩效新规|东方红资产管理10年给东方证券分红31.7亿,2022至2023给基民亏480亿元分红率却连续两年超过86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591601457","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591601457?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 15:48","pubTimestamp":1765871280,"startTime":"0","endTime":"0","summary":" 根据东方证券、上海东方证券资产管理有限公司财报数据,2024年东方红资产管理营收14.38亿元,净利润3.33亿元。东方证券持有东方红资产管理100%的股权。 值得注意的是,东方红资产管理在2022和2023年度,分红率分别是96.59%、86.63%,在大中型基金公司里处于较高水平。与此同时,2022年东方红资产管理旗下产品合计给基民亏损了340亿元,2023年东方红资产管理旗下产品合计给基民亏损了142亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-12-16/doc-inhaysii9995433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1229","BK0276","BK0012","09983","BK0188","600958","BK0183","BK1564","BK1147","BK1542","BK1583","BK0028","03958","BK1258"],"gpt_icon":0},{"id":"2591078605","title":"GLP-1赛道或再扩容!信达生物玛仕度肽青少年Ib期临床研究达主要终点 抢滩百亿减重市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2591078605","media":"蓝鲸新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591078605?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 14:54","pubTimestamp":1765868082,"startTime":"0","endTime":"0","summary":"【GLP-1赛道或再扩容!信达生物玛仕度肽青少年Ib期临床研究达主要终点 抢滩百亿减重市场】国内尚无任何儿童、青少年减重药物获批。信达生物GCG/GLP-1双受体激动剂玛仕度肽开始拓展青少年肥胖人群适应症。近日,信达生物公告,玛仕度肽在中国青少年肥胖人群中的Ib期临床研究达到主要终点。信达方面表示,基于该Ib期积极的安全性和疗效结果,信达生物计划于近期启动一项在青少年肥胖或超重参与者中的注册临床III期研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512163592954568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1589","LU2097828557.USD","LU2242644610.SGD","LU2328871848.SGD","GLP","LU2097828805.USD","BK4590","HK0000165453.HKD","BK1583","01801","LU1969619763.USD","LU2097828631.EUR","LU0455707207.USD","LU2488822045.USD","BK4144","LU0502904849.HKD","LU2097828474.EUR","BK1161","LU2097828714.EUR"],"gpt_icon":0},{"id":"2591609250","title":"【医疗与消费周度观点】创新药行业研发突破与市场演进的并行","url":"https://stock-news.laohu8.com/highlight/detail?id=2591609250","media":"大胡子产业经济","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591609250?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 14:10","pubTimestamp":1765865456,"startTime":"0","endTime":"0","summary":"投资要点医疗新观察创新药行业研发突破与市场演进的并行创新药物是指具有自主知识产权专利的药品,需通过双盲随机对照试验验证有效性与安全性,研发过程呈现高投入、长周期、高风险特点,通常涉及靶向治疗、基因编辑等前沿技术,区别于仅需完成药学质量一致性和生物等效性试验的仿制药。未来,我国创新药行业同时面临多种机遇和挑战。首次同步发布的商保创新药目录纳入了19种药品,标志着多层次医疗保障体系取得实质性突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216143530a6a83e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216143530a6a83e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06978","BK1574","01877","BK1515","BK1161"],"gpt_icon":0},{"id":"2591760341","title":"百融云创旗下数融小贷新上任一副总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2591760341","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591760341?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 14:10","pubTimestamp":1765865455,"startTime":"0","endTime":"0","summary":"12月15日,广州市地方金融管理局发布公告,同意房刚担任广州数融互联网小额贷款有限公司副总经理。数融小贷为上市公司百融云创的全资子公司,也是百融云旗下从事助贷、贷超业务的核心主体,旗下关联的商标和产品包括榕树贷款、钱小乐等。2025上半年,百融云创实现营收16.12亿元,同比增长22%;期内实现净利润2.01亿元,同比增长41%。虽然百融云创的叙事一直是AI,但是其助贷业务比例并不小。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1765865413416566878","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1131","06608","BK1575","BK1583","BK1587"],"gpt_icon":0},{"id":"2591670547","title":"房企司法重整第一股诞生!涉及债务规模达1470亿元,债权人数量超8400家,金科股份历时两年半完成重整","url":"https://stock-news.laohu8.com/highlight/detail?id=2591670547","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591670547?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 12:24","pubTimestamp":1765859040,"startTime":"0","endTime":"0","summary":" 12月15日晚间,金科股份发布《关于公司及控股子公司重整计划执行完毕的公告》。这标志着金科股份成为全国首家通过司法重整实现风险化解的“千亿级”上市房企。 本次重整中,金科股份及重庆金科涉及的债务规模达1470亿元,债权人数量超8400家,不仅是房地产行业迄今最大的重整案,也是重庆市有史以来最大的重整案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2025-12-16/doc-inhaymzi3233155.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-12-16/doc-inhaymzi3233155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1258","BK1542","BK1583","BK1229","09666"],"gpt_icon":0},{"id":"2591606026","title":"最新消息! 药明巨诺前CEO刘敏加盟博锐生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2591606026","media":"药研网","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591606026?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 11:54","pubTimestamp":1765857246,"startTime":"0","endTime":"0","summary":"据业内消息,刘敏辞任药明巨诺后,下一站已经确定,仍是一家国内创新药企。董事会同时表示,将于本月31日前废止执行委员会机制,由刘敏全面负责公司的战略规划、经营管理及组织建设,并向董事会汇报工作。值得注意的是,刘敏此次加盟博锐生物距离他12月12日辞去药明巨诺CEO及董事会主席职务仅三天,并放弃了超420万份未授予购股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216140628a6a826bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216140628a6a826bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2591609298","title":"医疗健康产业日报(12.15) : \"医药行业动态:融资、研发与政策利好\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2591609298","media":"亿欧","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591609298?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 11:13","pubTimestamp":1765854785,"startTime":"0","endTime":"0","summary":"消息面上,12月13日,全国医疗保障工作会议在北京召开。其中包括,合理提升产前检查医疗费用保障水平,力争全国基本实现政策范围内分娩个人“无自付”。截止目前,本月已完成回购3094.6万股,总金额7751.5万港币。2022年中国癌症病例及死亡人数达482.47万和257.42万,疾病负担沉重。这些公司密集公告 12月14日晚间,多只医药股发布利好消息。圣桐特医在婴儿特医食品行业位居第三,市占率9.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216111533a45086b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216111533a45086b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","09939","01877","BK1583","BK1161"],"gpt_icon":0},{"id":"2591672837","title":"西安市科技局2024年预算编制不精准、项目管理不到位、资产管理不规范","url":"https://stock-news.laohu8.com/highlight/detail?id=2591672837","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591672837?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 11:09","pubTimestamp":1765854540,"startTime":"0","endTime":"0","summary":"12月15日,西安市审计局公告披露,市科学技术局2024年度存在预算编制不精准、项目管理不到位、资产管理不规范等问题,应引起重视并加以纠正和改进。2024年,市科技局部门综合预算共计212426.15万元。审计结果表明,市科技局提供的财务及相关资料基本真实反映了2024年度预算执行和其他财政收支情况,支出基本符合《中华人民共和国预算法》及相关财经法规和财务制度。具体整改情况由市科技局在审计机关公告审计结果之日起三十日内向社会公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-12-16/doc-inhayftq0138585.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-16/doc-inhayftq0138585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1542","BK1258","BK1583","BK1229","09983"],"gpt_icon":0},{"id":"2591745626","title":"港股异动 | 光伏股再度走弱 光伏协会确认收储平台成立 光伏玻璃价格仍然承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2591745626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591745626?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 10:48","pubTimestamp":1765853321,"startTime":"0","endTime":"0","summary":"消息面上,光伏协会确认了“光和谦成”公司为产能收储平台。此外有传言称,后续各大光伏企业将持续注资约300亿元开启产能收储工作。当前天然气陆续开始执行冬气价,成本有所上涨,而光伏玻璃价格继续下行,行业亏损程度不断加大。整体来看,由于下游订单明显不足,行业供需差较大,短期光伏玻璃价格仍有下行压力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1148","IE0008369823.USD","IE00BZ08YR35.GBP","LU1785774172.SGD","03606","LU0269904917.USD","LU1983299162.USD","LU0327786744.USD","BK1144","LU0051755006.USD","LU1655091616.SGD","IE0034224299.USD","BK1589","LU0455707207.USD","BK1169","BK1509","06865","BK1594","IE00B031HY20.USD","LU0456827905.SGD","01799","00968","BK1554","LU2242644610.SGD","IE00BZ08YS42.EUR","LU0502904849.HKD","BK1583","IE0008368742.USD","LU0572944931.SGD","LU0972618739.USD","LU0509642566.USD","IE00BZ08YT58.USD","SG9999014674.SGD","LU0828238088.HKD"],"gpt_icon":0},{"id":"2591083496","title":"美团找房低调上线仍处测试阶段,合作接入房源未设独立入口","url":"https://stock-news.laohu8.com/highlight/detail?id=2591083496","media":"中华建设网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591083496?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 10:38","pubTimestamp":1765852723,"startTime":"0","endTime":"0","summary":"美团低调切入房产信息服务赛道。12月初,美团及大众点评APP在“小区”页面内上线“美团找房”板块,提供租房与二手房信息展示。对于依赖流量吸引经纪人购买端口的美团找房而言,若其入口持续隐藏在小区页面的二级甚至三级目录中,流量导入效果将十分有限,这势必影响经纪人的入驻意愿和端口付费积极性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216124517a6a7ea2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216124517a6a7ea2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1481107354.HKD","LU2488822045.USD","LU0132412106.USD","LU1048588211.SGD","LU0261950983.USD","LU0228659784.USD","BK1575","LU0417516738.SGD","LU1008478684.HKD","LU0541501648.USD","BK1583","LU1102505929.USD","LU0164872284.USD","LU0589944569.HKD","LU1734074674.USD","LU1868837722.USD","LU0164865239.USD","LU2778985437.USD","IE00B0JY6N72.USD","LU0823041008.USD","LU0117841782.USD","LU0348827113.USD","83690","LU0819123356.HKD","LU0449515922.USD","SG9999002562.SGD","LU1023057109.AUD","LU1224709979.USD","LU2242644610.SGD","03690","HMTD.SI","LU0880133367.SGD","LU1868838027.USD","LU2097828805.USD","LU0348816934.USD","LU2226246903.HKD","LU1226287529.USD","LU1242518857.USD","LU0650527681.SGD","LU1770034418.SGD","LU0307460666.USD","LU0047713382.USD","LU1152091168.USD","LU0181495838.USD","METmain","MPNGY","LU0067412154.USD","LU2045819591.USD","LU0633140560.USD","LU1961090484.USD","LU2097828714.EUR"],"gpt_icon":1},{"id":"2591671343","title":"《股市简讯》中国民营肿瘤医院集团海吉亚医疗涨6.5%,拟斥至少3亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2591671343","media":"路透中文","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591671343?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 10:19","pubTimestamp":1765851546,"startTime":"0","endTime":"0","summary":"《股市简讯》中国民营肿瘤医院集团海吉亚医疗涨6.5%,拟斥至少3亿元回购股份* 经营民营肿瘤医院的中国海吉亚医疗6078.HK周二早盘高开3.8%,随后涨幅扩大至6.5%。* 该公司此前公告称,董事会已议决利用购回授权,以不时在公开市场上按不少于3亿元人民币的总价格购回股份。* 海吉亚医疗今年迄今大跌15.8%,同期恒生指数.HSI上扬25.8%。* 恒生综合行业指数 - 医疗保健业.HSCIH盘中一度跌1.9%。(完)更多股市简讯请点选CN-CMN-HOT (发稿 徐凯文;审校 林高丽) ((kaiwen.xu@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nL4S3XM04A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0329678170.USD","LU0329678337.USD","LU0737861772.HKD","BK1583","LU2488822045.USD","BK1209","06078"],"gpt_icon":0},{"id":"2591671865","title":"海吉亚医疗(06078.HK)早盘涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591671865","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591671865?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 09:47","pubTimestamp":1765849645,"startTime":"0","endTime":"0","summary":"每经AI快讯,海吉亚医疗(06078.HK)早盘涨近6%,截至发稿,涨5.85%,报12.31港元,成交额3947.42万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512163592725552.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512163592725552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0329678170.USD","BK1209","LU0737861772.HKD","BK1583","06078","LU0329678337.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2591608402","title":"【券商聚焦】海通国际:医药板块短期承压 长期看好创新药产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2591608402","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591608402?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 09:43","pubTimestamp":1765849420,"startTime":"0","endTime":"0","summary":"金吾财讯|海通国际发布研报指,本周恒生医疗保健指数下跌2.3%,跑输恒生指数1.8个百分点,主要受南下资金年底季节性结账影响。2025年初至今,该指数累计涨幅达68.3%,大幅跑赢恒生指数38.8个百分点。子板块中CXO/科研服务表现最佳,医疗器械跌幅最大。长期来看,机构看好业绩确定性强的互联网医疗、CXO/科研服务龙头,以及具备海外授权合作能力的头部Biotech。风险提示包括临床进展不及预期、集采政策风险及宏观环境不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216095428a4503682&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216095428a4503682&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","SGXZ62798434.SGD","BK1515","06618","BK1615","SGXZ86797644.SGD","BK1589","06978","BK1247","09939","BK1142","BK1571","BK1574","LU0051755006.USD","LU0456827905.SGD","BK1591","86618","00241","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":1,"totalSize":886,"code":"91000000","status":"200"}]}}